Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
Piper Sandler analyst Edward Tenthoff maintains $Opko Health(OPK.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 31.4% and
HC Wainwright & Co. Reiterates Buy on OPKO Health, Maintains $3 Price Target
Opko Health (OPK) Receives a Buy From Piper Sandler
H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
H.C. Wainwright analyst Yi Chen maintains $Opko Health(OPK.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 30.5% and a
Opko Health Subsidiary Restructures With Strategic Sale and Debt Settlement
Express News | Labcorp Completes Acquisition of Select Assets of Bioreference Health's Diagnostics Business From OPKO Health
Roth MKM Says Small-Cap Value Reaches Key Technical Support, Lists 14 "Bullish" Stocks
Express News | Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
OPKO Health Is Maintained at Outperform by Barrington Research
OPKO Health Analyst Ratings
OPKO Health Shares Are Trading Higher After the Company Reported Better-than-expected Q2 EPS Results.
OPKO Health (OPK) Q2 Earnings Top Estimates, Gross Margin Down
Earnings Call: OPKO Health Q2 2024 Financials and Strategic Updates
Opko Health Holds Strong Buy Rating: Financial Resilience and Strategic Growth Fuel Optimism
Buy Rating Affirmed for OPKO Health Amid Strategic Partnerships and Promising Pipeline Developments
Barrington Research Adjusts OPKO Health's PT to $2.25 From $1.50, Keeps In Line Rating
Express News | OPKO Health Inc : Barrington Research Raises Target Price to $2.25 From $1.5
Opko Health (OPK) Q2 2024 Earnings Call Transcript
Earnings Call Summary | Opko Health(OPK.US) Q2 2024 Earnings Conference
OPKO Health, Inc. (OPK) Q2 2024 Earnings Call Transcript